JYPC(SZ:002198)2022-12-07 09:34Group 1: Natural Borneol Project - The purity of the company's natural borneol extraction ranges between 96% and 99%, with market prices for 96% purity around 3000 to 5000 RMB per kilogram [2][3] - The company has established pilot production lines for extraction and purification, which have been operational for over 2 years, with an expected annual capacity of 250 tons post-completion of facilities [3][4] - The domestic market demand for natural right-handed borneol is approximately 650 tons per year, while international demand is about 10,500 tons per year, indicating a significant market opportunity due to supply shortages [4][5] Group 2: Company Performance - The company's revenue for the first three quarters of the year reached 395 million RMB, with a net profit of 68 million RMB, reflecting a year-on-year growth of 325.29% [5][6] - The expected net profit for the entire year is projected to be between 68 million and 73 million RMB [5][6] - The subsidiary, Jinsan Pharmaceutical, is expected to achieve a net profit of 58.25 million RMB as per the profit compensation agreement [6][7] Group 3: Investment and Market Strategy - The company plans to focus future investments on the traditional Chinese medicine sector, emphasizing profitability in potential investments [7][8] - There is currently no intention to acquire hospitals or traditional Chinese medicine enterprises [7][8] - The company aims to enhance its market share and brand through increased advertising and sales team expansion, while also exploring external investments to improve overall profitability [8]